Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Greenberg

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Journal of Cardiac Failure|August 25, 2009
A potential shift from adaptive immune activity to nonspecific inflammatory activation associated with higher depression symptoms in chronic heart failure patientsLaura S Redwine, Petra H Wirtz, Suzi Hong, et al.
Nature Reviews. Disease Primers|August 25, 2017
Heart failure with reduced ejection fractionMichelle W Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Benefit versus Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary EraVincenzo Cusi, Florin Vaida, Nicholas Wettersten, et al.
JACC. Heart Failure|April 25, 2026
Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National SurveyElizabeth Silver, Megan Punt, Jessica Wang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2004
Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiationJoseph Milano, Jenny McKay, Claude Dagenais, et al.
Journal of Cardiac Failure|November 13, 2007
Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trialBarry Greenberg, Barbara Czerska, William T Abraham, et al.
Circulation|June 29, 2011
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failureMariell Jessup, Barry Greenberg, Donna Mancini, et al.
JACC. Heart Failure|March 14, 2014
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)Barry Greenberg, Alex Yaroshinsky, Krisztina M Zsebo, et al.
European Journal of Heart Failure|May 4, 2022
Improving clinical trial efficiency using a machine learning-based risk score to enrich study populationsKarola S Jering, Claudio Campagnari, Brian Claggett, et al.
Bone Research|February 10, 2022
The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone developmentFatma F Mohamed, Chunxi Ge, Randy T Cowling, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Journal of Cardiac Failure|August 25, 2009
A potential shift from adaptive immune activity to nonspecific inflammatory activation associated with higher depression symptoms in chronic heart failure patientsLaura S Redwine, Petra H Wirtz, Suzi Hong, et al.
Nature Reviews. Disease Primers|August 25, 2017
Heart failure with reduced ejection fractionMichelle W Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Benefit versus Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary EraVincenzo Cusi, Florin Vaida, Nicholas Wettersten, et al.
JACC. Heart Failure|April 25, 2026
Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National SurveyElizabeth Silver, Megan Punt, Jessica Wang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2004
Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiationJoseph Milano, Jenny McKay, Claude Dagenais, et al.
Journal of Cardiac Failure|November 13, 2007
Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trialBarry Greenberg, Barbara Czerska, William T Abraham, et al.
Circulation|June 29, 2011
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failureMariell Jessup, Barry Greenberg, Donna Mancini, et al.
JACC. Heart Failure|March 14, 2014
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)Barry Greenberg, Alex Yaroshinsky, Krisztina M Zsebo, et al.
European Journal of Heart Failure|May 4, 2022
Improving clinical trial efficiency using a machine learning-based risk score to enrich study populationsKarola S Jering, Claudio Campagnari, Brian Claggett, et al.
Bone Research|February 10, 2022
The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone developmentFatma F Mohamed, Chunxi Ge, Randy T Cowling, et al.
Pageof 19